| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.8286 | 26 |
| GSM780708 | Untreated after 4 days (C2_1) | 51.8715 | 54 |
| GSM780709 | Untreated after 4 days (C3_1) | 53.734 | 57 |
| GSM780719 | Untreated after 4 days (C1_2) | 63.057 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.9783 | 51 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.7459 | 60 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.9617 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.1336 | 54 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.8961 | 48 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.9309 | 48 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 57.5857 | 62 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.1038 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.742 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 54.5605 | 59 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 58.4835 | 63 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 59.291 | 64 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.8289 | 62 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.395 | 55 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.5908 | 30 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.1267 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.2136 | 60 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.3927 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.5561 | 53 |